Oregon Public Employees Retirement Fund raised its holdings in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 3.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,786 shares of the company’s stock after purchasing an additional 666 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Medidata Solutions were worth $1,836,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Wsfs Capital Management LLC bought a new position in Medidata Solutions during the 2nd quarter valued at approximately $2,651,000. Federated Investors Inc. PA raised its position in Medidata Solutions by 57.9% during the 2nd quarter. Federated Investors Inc. PA now owns 36,284 shares of the company’s stock valued at $2,923,000 after purchasing an additional 13,301 shares during the last quarter. Great West Life Assurance Co. Can raised its position in Medidata Solutions by 4.5% during the 2nd quarter. Great West Life Assurance Co. Can now owns 34,943 shares of the company’s stock valued at $2,815,000 after purchasing an additional 1,503 shares during the last quarter. Dimensional Fund Advisors LP raised its position in Medidata Solutions by 3.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 134,580 shares of the company’s stock valued at $10,841,000 after purchasing an additional 3,992 shares during the last quarter. Finally, Janus Henderson Group PLC raised its position in Medidata Solutions by 69.7% during the 2nd quarter. Janus Henderson Group PLC now owns 1,904,094 shares of the company’s stock valued at $153,394,000 after purchasing an additional 782,194 shares during the last quarter.

In related news, Director Lee Shapiro sold 12,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 26th. The stock was sold at an average price of $76.16, for a total transaction of $952,000.00. Following the completion of the transaction, the director now owns 26,028 shares of the company’s stock, valued at approximately $1,982,292.48. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Michael I. Otner sold 9,288 shares of the firm’s stock in a transaction that occurred on Tuesday, July 24th. The shares were sold at an average price of $81.03, for a total value of $752,606.64. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 32,788 shares of company stock valued at $2,574,487. 4.70% of the stock is owned by corporate insiders.

Shares of NASDAQ:MDSO opened at $80.53 on Friday. Medidata Solutions Inc has a 52-week low of $59.60 and a 52-week high of $88.87. The company has a market capitalization of $4.80 billion, a PE ratio of 82.94, a PEG ratio of 5.04 and a beta of 1.45. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.41 and a quick ratio of 1.41.

Medidata Solutions (NASDAQ:MDSO) last announced its earnings results on Tuesday, July 24th. The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.04. Medidata Solutions had a return on equity of 11.37% and a net margin of 9.13%. The firm had revenue of $155.90 million during the quarter, compared to analyst estimates of $155.86 million. During the same quarter in the prior year, the company earned $0.31 EPS. The business’s revenue was up 14.6% compared to the same quarter last year. equities research analysts forecast that Medidata Solutions Inc will post 0.79 EPS for the current year.

MDSO has been the subject of a number of recent analyst reports. Morgan Stanley lowered Medidata Solutions from an “overweight” rating to a “hold” rating and set a $79.00 price target for the company. in a research report on Monday, May 21st. Piper Jaffray Companies increased their target price on Medidata Solutions to $98.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 23rd. Deutsche Bank increased their target price on Medidata Solutions from $78.00 to $85.00 and gave the stock a “buy” rating in a research report on Thursday, May 31st. BidaskClub raised Medidata Solutions from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, June 5th. Finally, Needham & Company LLC increased their target price on Medidata Solutions from $80.00 to $90.00 and gave the stock a “buy” rating in a research report on Wednesday, June 13th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $87.62.

About Medidata Solutions

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.

Recommended Story: Closed-End Mutual Funds

Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.